Melanotan-I
- Delivery within 1-2 business days
- Pickup at collection point available
- Discreetly packaged
Secure payments
Order before 14:00 for same-day shipping
Order within 00 hours 00 minutes
Melanotan I is a synthetic peptide consisting of 13 amino acids. Within research contexts, this molecule is known for its interactions with melanocortin receptors and pigmentation-related research models.
Melanotan I is studied in scientific settings due to possible interactions with melanocortin pathways, pigmentation processes, and hormonal signaling mechanisms. The peptide is an analogue of the α-MSH hormone and is studied within models related to melanocortin receptor activity.
Research relevance
Studied within models of melanocortin receptor activity.
Relevant in studies on pigmentation processes.
Examined in relation to α-MSH-related signaling mechanisms.
Applied in experimental setups involving receptor interactions.
Key specifications
Feature | Value / explanation |
|---|---|
Peptide type | Melanocortin analogue (Melanotan I) |
Number of amino acids | 13 |
Available variant | 10mg |
Tested for | Purity, endotoxins and heavy metals |
Form | Lyophilized (lyophilisate, dry powder) |
Storage & shelf life | Lyophilized: shelf life of 2 years. Batch: PK-RG-009 Best before: February 4, 2028 |
Lab results
Variant | Lab report (COA) |
|---|---|
Melanotan I 10mg |
Specifications
| Concentration (mg) | 10mg |
| Bacteriostatic Water | 10ml, 3ml (included by default) |
| Insulin Needles | 10x 0.5ml insulin needles, 10x 1ml insulin needles, None |
| Alcohol Swabs | No, Yes |
- Netherlands & Belgium: 1-2 business days, €4.95-€9.95
- Germany: 3-7 business days, €9.95
- Rest of Europe: 3-7 business days, €14.95
- Shipped from the Netherlands · Discreet packaging · Tracking included
- Free shipping on orders over €250
- Intended exclusively for research purposes.
- Not intended for human use, diagnosis, or treatment.
- Only for qualified personnel in a controlled research environment.
- By purchasing this product, you confirm that you have read these terms of use and agree to standard research practices.
